Literature DB >> 27061307

Gestational age is more important for short-term neonatal outcome than microbial invasion of the amniotic cavity or intra-amniotic inflammation in preterm prelabor rupture of membranes.

Adriano Rodríguez-Trujillo1, Teresa Cobo1,2, Irene Vives1, Jordi Bosch3, Marian Kacerovsky4, David E Posadas1, Martina A Ángeles1, Eduard Gratacós1,2, Bo Jacobsson5,6, Montse Palacio1,2.   

Abstract

INTRODUCTION: The aim of this study was to evaluate, in women with preterm prelabor rupture of membranes (PPROM), the impact on short-term neonatal outcome of microbial invasion of the amniotic cavity (MIAC), intra-amniotic inflammation (IAI), and the microorganisms isolated in women with MIAC, when gestational age is taken into account.
MATERIAL AND METHODS: Prospective cohort study. We included women with PPROM (22.0-34.0 weeks of gestation) with available information about MIAC, IAI and short-term neonatal outcome. MIAC was defined as positive aerobic/anaerobic/genital Mycoplasma culture in amniotic fluid. Definition of IAI was based on interleukin-6 levels in amniotic fluid. Main outcome measures were Apgar score <7 at 5 min, umbilical artery pH ≤7.0, days in the neonatal intensive care unit, and composite neonatal morbidity, including any of the following: intraventricular hemorrhage grade III-IV, respiratory distress syndrome, early-onset neonatal sepsis, periventricular leukomalacia, necrotizing enterocolitis, and fetal or neonatal death. Labor was induced after 32.0 weeks if lung maturity was confirmed; and otherwise after 34.0 weeks.
RESULTS: MIAC and IAI were found in 38% (72/190) and 67% (111/165), respectively. After adjustment for gestational age at delivery, no differences in short-term neonatal outcome were found between women with either MIAC or IAI, compared with the non-infection/non-inflammation ("No-MIAC/No-IAI") group. Furthermore, short-term neonatal outcome did not differ between the MIAC caused by Ureaplasma spp. group, the MIAC caused by other microorganisms group and the "No-MIAC/No-IAI" group.
CONCLUSIONS: Gestational age at delivery seems to be more important for short-term neonatal outcome than MIAC or IAI in PPROM.
© 2016 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Interleukin-6; intra-amniotic inflammation; microbial invasion of the amniotic cavity; preterm birth; preterm prelabor rupture of membranes; short-term neonatal outcome

Mesh:

Year:  2016        PMID: 27061307     DOI: 10.1111/aogs.12905

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  16 in total

1.  Late preterm prelabor rupture of fetal membranes: fetal inflammatory response and neonatal outcome.

Authors:  Ivana Musilova; Ctirad Andrys; Marcela Drahosova; Barbora Zednikova; Helena Hornychova; Lenka Pliskova; Helena Zemlickova; Bo Jacobsson; Marian Kacerovsky
Journal:  Pediatr Res       Date:  2017-12-20       Impact factor: 3.756

2.  Evidence that intra-amniotic infections are often the result of an ascending invasion - a molecular microbiological study.

Authors:  Roberto Romero; Nardhy Gomez-Lopez; Andrew D Winters; Eunjung Jung; Majid Shaman; Janine Bieda; Bogdan Panaitescu; Percy Pacora; Offer Erez; Jonathan M Greenberg; Madison M Ahmad; Chaur-Dong Hsu; Kevin R Theis
Journal:  J Perinat Med       Date:  2019-11-26       Impact factor: 1.901

3.  Optimization and validation of two multiplex qPCR assays for the rapid detection of microorganisms commonly invading the amniotic cavity.

Authors:  Andrew D Winters; Roberto Romero; Emma Graffice; Nardhy Gomez-Lopez; Eunjung Jung; Tomi Kanninen; Kevin R Theis
Journal:  J Reprod Immunol       Date:  2021-12-08       Impact factor: 4.054

4.  Presence of Chlamydia trachomatis DNA in the amniotic fluid in women with preterm prelabor rupture of membranes.

Authors:  Marian Kacerovsky; Roberto Romero; Lenka Pliskova; Radka Bolehovska; Helena Hornychova; Adela Matejkova; Hana Vosmikova; Ctirad Andrys; Martina Kolackova; Piotr Laudański; Vera Pelantova; Bo Jacobsson; Ivana Musilova
Journal:  J Matern Fetal Neonatal Med       Date:  2019-07-15

5.  Antibiotic administration reduces the rate of intraamniotic inflammation in preterm prelabor rupture of the membranes.

Authors:  Marian Kacerovsky; Roberto Romero; Martin Stepan; Jaroslav Stranik; Jan Maly; Lenka Pliskova; Radka Bolehovska; Vladimir Palicka; Helena Zemlickova; Helena Hornychova; Jiri Spacek; Bo Jacobsson; Percy Pacora; Ivana Musilova
Journal:  Am J Obstet Gynecol       Date:  2020-07       Impact factor: 10.693

6.  Maternal white blood cell count cannot identify the presence of microbial invasion of the amniotic cavity or intra-amniotic inflammation in women with preterm prelabor rupture of membranes.

Authors:  Ivana Musilova; Lenka Pliskova; Romana Gerychova; Petr Janku; Ondrej Simetka; Petr Matlak; Bo Jacobsson; Marian Kacerovsky
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

7.  Maternal serum C-reactive protein concentration and intra-amniotic inflammation in women with preterm prelabor rupture of membranes.

Authors:  Ivana Musilova; Marian Kacerovsky; Martin Stepan; Tomas Bestvina; Lenka Pliskova; Barbora Zednikova; Bo Jacobsson
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

8.  Predictive factors and clinical practice profile for strictures post-necrotising enterocolitis.

Authors:  Han Zhang; Jiaping Chen; Yan Wang; Chun Deng; Lei Li; Chunbao Guo
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

9.  Clinical significance of histologic chorioamnionitis with a negative amniotic fluid culture in patients with preterm labor and premature membrane rupture.

Authors:  Jeong Woo Park; Kyo Hoon Park; Eun Young Jung
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

10.  Components of the antepartum, intrapartum, and postpartum exposome impact on distinct short-term adverse neonatal outcomes of premature infants: A prospective cohort study.

Authors:  Unzila Ali Nayeri; Catalin S Buhimschi; Guomao Zhao; Irina A Buhimschi; Vineet Bhandari
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.